title: Outcomes of second-line treatment in chronic lymphocytic leukemia - a population-based study from a well defined geographical region between 2003 and 2013.
authors.affiliation: a Department of Oncology-Pathology , Karolinska Institutet , Stockholm , Sweden.|b Department of Oncology , Karolinska University Hospital , Stockholm , Sweden.
authors.forename: Anna
authors.initials: A
authors.lastname: Asklid
authors.affiliation: a Department of Oncology-Pathology , Karolinska Institutet , Stockholm , Sweden.|d Department of Hematology , Karolinska University Hospital Solna , Stockholm , Sweden.
authors.forename: Maria
authors.initials: M
authors.lastname: Winqvist
authors.affiliation: a Department of Oncology-Pathology , Karolinska Institutet , Stockholm , Sweden.
authors.forename: Sandra
authors.initials: S
authors.lastname: Eketorp Sylvan
authors.affiliation: a Department of Oncology-Pathology , Karolinska Institutet , Stockholm , Sweden.|c Department of Internal Medicine , Södersjukhuset , Stockholm , Sweden.
authors.forename: Agnes
authors.initials: A
authors.lastname: Mattsson
authors.affiliation: a Department of Oncology-Pathology , Karolinska Institutet , Stockholm , Sweden.|b Department of Oncology , Karolinska University Hospital , Stockholm , Sweden.
authors.forename: Einar
authors.initials: E
authors.lastname: Björgvinsson
authors.affiliation: e Janssen Nordic , Birkerød , Denmark.
authors.forename: Frans
authors.initials: F
authors.lastname: Søltoft
authors.affiliation: f Previously at Janssen Nordic , Stockholm , Sweden.
authors.forename: Johanna
authors.initials: J
authors.lastname: Repits
authors.affiliation: g Janssen EMEA , Antwerp , Belgium.
authors.forename: Joris
authors.initials: J
authors.lastname: Diels
authors.affiliation: a Department of Oncology-Pathology , Karolinska Institutet , Stockholm , Sweden.|d Department of Hematology , Karolinska University Hospital Solna , Stockholm , Sweden.
authors.forename: Anders
authors.initials: A
authors.lastname: Österborg
authors.affiliation: a Department of Oncology-Pathology , Karolinska Institutet , Stockholm , Sweden.|d Department of Hematology , Karolinska University Hospital Solna , Stockholm , Sweden.
authors.forename: Lotta
authors.initials: L
authors.lastname: Hansson
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000175:diagnosis / Q000453:epidemiology* / Q000401:mortality / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D060787:Neoplasm Grading; D009367:Neoplasm Staging; D011159:Population Surveillance; D012008:Recurrence; D012042:Registries; D019233:Retreatment; D012189:Retrospective Studies; D016019:Survival Analysis; D013548:Sweden / Q000453:epidemiology; D016896:Treatment Outcome